MEDI 475-Discovery of orally active met kinase inhibitors

被引:0
|
作者
Cai, Zhen-wei [1 ]
机构
[1] Bristol Myers Squibb Co, Bristol Myers Squibb R&D, Discovery Chem, Princeton, NJ 08543 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
475-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors
    Cai, Zhen-Wei
    Wei, Donna
    Schroeder, Gretchen M.
    Cornelius, Lyndon A. M.
    Kim, Kyoung
    Chen, Xiao-Tao
    Schmidt, Robert J.
    Williams, David K.
    Tokarski, John S.
    An, Yongmi
    Sack, John S.
    Manne, Veeraswamy
    Kamath, Amrita
    Zhang, Yueping
    Marathe, Punit
    Hunt, John T.
    Lombardo, Louis J.
    Fargnoli, Joseph
    Borzilleri, Robert M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) : 3224 - 3229
  • [2] Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors
    Cho, Sung Yun
    Han, Sun-Young
    Ha, Jae Du
    Ryu, Jae Wook
    Lee, Chong Ock
    Jung, Heejung
    Kang, Nam Sook
    Kim, Hyoung Rae
    Koh, Jong Sung
    Lee, Jongkook
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (14) : 4223 - 4227
  • [3] Discovery of novel and orally active inhibitors of lck kinase.
    Goldberg, D
    Butz, T
    Cardozo, M
    Eckner, R
    Hammach, A
    Huang, J
    Jakes, S
    Kapadia, S
    Lukas, S
    Morwick, T
    Moss, N
    Panzenbeck, M
    Patel, U
    Peet, G
    Peterson, J
    Prokopowicz, A
    Snow, RJ
    Takahashi, H
    Tan, J
    Tschantz, M
    Wang, XJ
    Xiang, P
    Zinter, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U643 - U643
  • [4] Discovery of Orally Active JNK Inhibitors
    Satoh, Yoshitaka
    INFLAMMATION RESEARCH, 2005, 54 : S134 - S135
  • [5] Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)
    Shakespeare, William
    Fantin, Valeria
    Wang, Frank
    Kohlmann, Anna
    Liu, Shuangying
    Huang, Wei-Sheng
    Wang, Yihan
    Zou, Dong
    Thomas, Mathew
    Li, Feng
    Qi, Jiwei
    Cai, Lisi
    Dwight, Thimothy
    Xu, Yongjin
    Xu, Rongsong
    Dodd, Rory
    Xu, Qihong
    Anjum, Rana
    Zhang, Sen
    Keats, Jeffrey
    Xue, Ling
    Wardwell, Scott
    Ning, Yaoyu
    Moran, Lauren
    Mohemmad, Qurish
    Zhu, Xiaotian
    Narasimhan, Narayana
    Rivera, Victor
    Dalgarno, David
    Clackson, Tim
    CANCER RESEARCH, 2009, 69
  • [6] Discovery of orally bioavailable Aurora kinase inhibitors
    Zhang, Yonglian
    Yu, Tao
    Tagat, Jayaram R.
    Xiao, Yushi
    Kerekes, Angela D.
    Doll, Ronald J.
    Esposite, Sara
    Hruza, Alan
    Voss, Matthew
    Rainka, Matthew
    Basso, Andrea D.
    Gray, Kimberly
    Tevar, Seema
    Kirschmeier, Paul
    Liu, Ming
    Liang, Lianzhu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [7] Discovery of orally bioavailable Aurora kinase inhibitors
    Belanger, David B.
    Williams, Michael J.
    Meng, Zhaoyang
    Yu, Tao
    Mandal, Amit K.
    Curran, Patrick J.
    Rainka, Matthew P.
    Shih, Neng-Yang
    Siddiqui, M. Arshad
    Basso, Andrea D.
    Prelusky, Daniel
    Liu, Ming
    Lee, Suining
    Yaremko, Bohdan
    Gray, Kimberly
    Tevar, Seema
    Jones, Jennifer
    Smith, Elizabeth B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [8] Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1
    Degnan, Andrew P.
    Kumi, Godwin K.
    Allard, Christopher W.
    Araujo, Erika, V
    Johnson, Walter L.
    Zimmermann, Kurt
    Pearce, Bradley C.
    Sheriff, Steven
    Futran, Alan
    Li, Xin
    Locke, Gregory A.
    You, Dan
    Morrison, John
    Parrish, Karen E.
    Stromko, Caitlyn
    Murtaza, Anwar
    Liu, Jinqi
    Johnson, Benjamin M.
    Vite, Gregory D.
    Wittman, Mark D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (03): : 443 - 450
  • [9] Discovery and progression of a novel series of orally active p38 kinase inhibitors.
    Leftheris, K
    Ahmed, G
    Chan, R
    Dyckman, A
    Hynes, J
    Lin, SQ
    Metzger, A
    Moriarty, K
    Shimshock, Y
    Wen, J
    Wityak, J
    Wrobleski, S
    Wu, H
    Wu, JJ
    Behnia, K
    Doweyko, AM
    Gillooly, K
    Lin, T
    Loo, D
    McIntyre, K
    Pitt, S
    Shen, DR
    Shuster, D
    Zhang, HJ
    Zhang, R
    Barrish, J
    Dodd, J
    Henderson, I
    Schieven, G
    Webb, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U939 - U939
  • [10] The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase
    Leftheris, K
    Ahmed, G
    Chan, R
    Dyckman, AJ
    Hussain, Z
    Ho, K
    Hynes, J
    Letourneau, J
    Li, W
    Lin, SQ
    Metzger, A
    Moriarty, KJ
    Riviello, C
    Shimshock, Y
    Wen, J
    Wityak, J
    Wrobleski, ST
    Wu, H
    Wu, JJ
    Desai, M
    Gillooly, KM
    Lin, TH
    Loo, D
    McIntyre, KW
    Pitt, S
    Shen, DR
    Shuster, DJ
    Zhang, R
    Diller, D
    Doweyko, A
    Sack, J
    Baldwin, J
    Barrish, J
    Dodd, J
    Henderson, I
    Kanner, S
    Schieven, GL
    Webb, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6283 - 6291